We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




World’s First Wireless, Wearable Doppler Ultrasound System Aids in Sepsis Management

By MedImaging International staff writers
Posted on 15 Mar 2023
Print article
Image: The FDA-approved FloPatch device provides a simple, fast, and consistent method for measuring changes in heart function (Photo courtesy of Flosonics)
Image: The FDA-approved FloPatch device provides a simple, fast, and consistent method for measuring changes in heart function (Photo courtesy of Flosonics)

Timing is crucial when caring for patients with sepsis. Upon a patient's arrival at a hospital suffering from sepsis, the initial course of action is to provide them with intravenous (IV) fluids. However, not all patients benefit from this method, and in fact, some may experience negative side effects from excessive IV fluid use, even at the early stages of treatment. This excess fluid can lead to complications, such as a longer hospital stay and more complicated care. While current tools can measure fluid response, they are often inconvenient and time-consuming. Now, a first-of-its-kind first wireless, wearable Doppler ultra-sound system aids clinicians in better managing IV fluid therapy during the early stages of sepsis care.

FloPatch, an innovative new technology from Flosonics Medical (Sudbury, ON, Canada), monitors blood flow in real-time. The FDA-approved device offers a fast, simple, and reliable way to measure changes in heart function. The device is placed on the patient's neck and continuously assesses blood flow in the carotid arteries, which are the main arteries supplying blood to the face, brain, and neck. The data collected is then wirelessly transmitted to a secure iOS mobile application, providing clinicians with actionable and real-time data at the bedside. As an easy-to-use, hands-free device, the FloPatch can be deployed in less than one minute.

FloPatch’s advanced analytics engine quantifies and displays changing metrics during an assessment, improving a clinician's ability to administer more precise fluid treatment and leading to better care for patients. A recent study demonstrated that four to five patients can avoid potentially dangerous fluid overload in the emergency department for every 10 FloPatch assessments performed, resulting in improved patient outcomes and significant cost savings.

“FloPatch is more than an innovative ultrasound system, it is a new paradigm linking physiology and resuscitation medicine,” said Dr. Jon-Emile Kenny, chief medical officer at Flosonics Medical.

Related Links:
Flosonics Medical

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
New
Ultrasound System
Aplio me
Brachytherapy Planning System
Oncentra Brachy

Print article

Channels

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.